help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Published ahead of print on September 8, 2005, doi:10.1164/rccm.200504-588OC

Am. J. Respir. Crit. Care Med., Volume 172, Number 11, December 2005, 1434-1439

A more recent version of this article appeared on December 1, 2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200504-588OCv1
172/11/1434    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, Y.-Q.
Right arrow Articles by Wu, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, Y.-Q.
Right arrow Articles by Wu, C.

Submitted on April 16, 2005
Accepted on September 8, 2005

CD4+CD25+ Regulatory T Lymphocytes in Malignant Pleural Effusion

Yi-Qiang Chen1, Huan-Zhong Shi1*, Xue-Jun Qin1, Wu-Ning Mo1, Xiang-Dong Liang1, Ze-Xin Huang1, Hai-Bo Yang1, and Cong Wu1

1 Institute of Respiratory Diseases, First Affiliated Hospital, Guangxi Medical University, Nanning, Guangxi, China

* To whom correspondence should be addressed. E-mail: hzshi{at}vip.tom.com.

Background: Active suppression by CD4+CD25+ regulatory T lymphocytes plays an important role in the down-regulation of T cell responses to foreign and self-antigens. Objective: To analyze whether the CD4+CD25+ regulatory T lymphocytes exist and function normally in malignant pleural effusion. Methods: The percentages of CD4+CD25+ T lymphocytes in pleural effusion and peripheral blood from lung cancer patients with malignant effusion, pleural lavage and peripheral blood from lung cancer patients without effusion, and peripheral blood from healthy control subjects were determined by flow cytometry. The expressions of forkhead transcription factor Foxp3 and cytotoxic lymphocyte associated antigen-4 were also examined. CD4+CD25+ and CD4+CD25- T cells from pleural effusion and peripheral blood were isolated, and were cultured to observe the effects of CD4+CD25+ cells on proliferation response of CD4+CD25- T cells in vitro. Main results: There were increased numbers of CD4+CD25+ T cells in malignant pleural effusion from patients with lung cancer compared with pleural lavage from lung cancer patients without pleural effusion, and that these cells have constitutive high-level expression of Foxp3 and cytotoxic lymphocyte associated antigen-4. Furthermore, CD4+CD25+ T cells mediate potent inhibition of proliferation response of CD4+CD25- T cells, and anti? cytotoxic lymphocyte associated antigen-4 monoclonal antibody could reduced the inhibitory activity of CD4+CD25+ T cells. Conclusions: The increased CD4+CD25+ T cells found in malignant pleural effusion express high level of Foxp3 transcription factor, potently suppress the proliferation of CD4+CD25- T cells, and cytotoxic lymphocyte associated antigen-4 is involved in the suppressive activity of pleural CD4+CD25+ T cells.


Key words: CD4+CD25+ T cells, Lung cancer, Pleural effusion, Regulatory T lymphocyte




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
X.-J. Qin, H.-Z. Shi, J.-M. Deng, Q.-L. Liang, J. Jiang, and Z.-J. Ye
CCL22 Recruits CD4-positive CD25-positive Regulatory T Cells into Malignant Pleural Effusion
Clin. Cancer Res., April 1, 2009; 15(7): 2231 - 2237.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. R. Jett and Y. E. Miller
Update in lung cancer 2005.
Am. J. Respir. Crit. Care Med., April 1, 2006; 173(7): 695 - 697.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2005 American Thoracic Society
  ATS Coding and Billing Quarterly